The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.

Nicole van Steijn, MD, shares how using smartwatches for AF screening can up diagnosis in older, high-risk patients.

Early data from the first phase III trial of Lilly’s triple agonist show reductions in weight and HbA1c for patients with ...

The 15-year data help support the idea that each test can aid in putting the other’s results in perspective, but questions ...

The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be ...

A study of more than 20,000 Californians shows that outcomes are better when echo is done at the recommended intervals.

Amidst stalled progress on reducing CV mortality, there remains work to do on easing the financial burden on patients.

New data from the PARTNER 3 low-risk trial of patients with symptomatic, severe aortic stenosis show that TAVI and SAVR are ...

In the diverse cohort, risks were particularly amplified in Black Americans, likely due to structural and environmental ...

In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.

Data are early, retrospective, and unlikely to influence guidelines, but interest among operators is growing, says Sameh ...